Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway. The first patient has already been treated with bemdaneprocel, a ...
The reduction in Bayer's workforce under turnaround chief executive Bill Anderson has reached around 12,000 – a fall of around 12% since the start of 2024 – and isn't yet completed. On the German ...
After launching an initial “frontrunner” a group in Illinois, Bayer says its Crop Science division is ready to roll out the company’s new operating model, Dynamic Shared Ownership (as it’s known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback